Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Vera Therapeutics announces inducement grants Under Nasdaq Listing Rule 5635(c)(4).
-
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Vera Therapeutics Appoints Christopher Hite to Board of Directors
-
Vera Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
-
Vera Therapeutics to Participate at Upcoming Investor Conferences
-
Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4).
-
Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer
-
Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4).
-
Vera Therapeutics to participate in the 44th Annual J.P. Morgan Healthcare Conference